"10.1371_journal.pone.0012596","plos one","2010-09-07T00:00:00Z","Ekaterini Blaveri; Fiona Kelly; Alessandra Mallei; Kriss Harris; Adam Taylor; Juliet Reid; Maria Razzoli; Lucia Carboni; Chiara Piubelli; Laura Musazzi; Girogio Racagni; Aleksander Math√©; Maurizio Popoli; Enrico Domenici; Stewart Bates","Medicines Research Centre, GlaxoSmithKline, Stevenage, United Kingdom; Center of Neuropharmacology-Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy; Neurosciences CEDD, GlaxoSmithKline Medicines Research Centre, Verona, Italy; Clinical Neuroscience‚ÄPsychiatry, Karolinska Insitutet, Huddinge Hospital, Stockholm, Sweden; Instituto Di Ricoverio e Cura a Carattere Scientifico, San Giovanni di Dio-Fatebenefratelli, Brescia, Italy; Cancer Research UK, London, United Kingdom","Conceived and designed the experiments: EB FK JR LC CP GR AAM MP ED SB. Performed the experiments: EB FK AM AT JR MR LM. Analyzed the data: EB FK KH AT MR LC CP LM MP ED. Contributed reagents/materials/analysis tools: AAM SB. Wrote the paper: EB FK MR LC AAM MP ED SB.","E Blaveri, S Bates, A Taylor, F Kelly, J Reid, K Harris, E Domenici, L Carboni, M Razzoli, C Piubelli are or were employees of GlaxoSmithKline and the study was partly funded by GlaxoSmithKline. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. None of the authors has patent applications on this work.","2010","09","Ekaterini Blaveri","EB",15,TRUE,10,7,10,8,TRUE,TRUE,FALSE,0,NA,FALSE
